These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33618079)

  • 1. Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease.
    Han DW; Jo KW; Kim OH; Shim TS
    Respir Med; 2021 Apr; 179():106340. PubMed ID: 33618079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kim OH; Chong YP; Shim TS; Jo KW
    J Infect Chemother; 2021 Aug; 27(8):1156-1161. PubMed ID: 33745810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kwon BS; Lee JH; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW
    Respir Med; 2019 Apr; 150():45-50. PubMed ID: 30961950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
    Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
    Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Jhun BW; Moon SM; Kim SY; Park HY; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease.
    Lee JK; Kim S; Chong YP; Lee HJ; Shim TS; Jo KW
    Chest; 2024 Sep; 166(3):442-451. PubMed ID: 38508335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort study.
    Oshitani Y; Kitada S; Edahiro R; Tsujino K; Kagawa H; Yoshimura K; Miki K; Miki M; Kida H
    Respir Res; 2020 Jan; 21(1):10. PubMed ID: 31915013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriological and pathological analysis on the pathogenetic factors for cavitary and nodular bronchiectatic type of pulmonary Mycobacterium avium-intracellulare complex disease].
    Okumura M; Iwai K; Yano I; Takahashi M; Kasumi Y; Tanaka S; Yoshiyama T; Ogata H; Nakajima Y; Azuma A; Kudoh S
    Nihon Kokyuki Gakkai Zasshi; 2006 Feb; 44(2):91-8. PubMed ID: 17228801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Fluoroquinolones as Substitutes for Ethambutol or Rifampin in the Treatment of Mycobacterium avium Complex Pulmonary Disease According to Radiologic Types.
    Lee JH; Park YE; Chong YP; Shim TS; Jo KW
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0152221. PubMed ID: 34930036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
    Lee G; Lee KS; Moon JW; Koh WJ; Jeong BH; Jeong YJ; Kim HJ; Woo S
    Ann Am Thorac Soc; 2013 Aug; 10(4):299-306. PubMed ID: 23952847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
    Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y
    BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial CT findings of nodular bronchiectatic Mycobacterium avium complex pulmonary disease with antibiotic treatment.
    Lee G; Kim HS; Lee KS; Koh WJ; Jeon K; Jeong BH; Ahn J
    AJR Am J Roentgenol; 2013 Oct; 201(4):764-72. PubMed ID: 24059365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease.
    Chae G; Park YE; Chong YP; Lee HJ; Shim TS; Jo KW
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0226121. PubMed ID: 35950842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural course of the nodular bronchiectatic form of Mycobacterium Avium complex lung disease: Long-term radiologic change without treatment.
    Park TY; Chong S; Jung JW; Park IW; Choi BW; Lim C; Lee CU; Kim YS; Choi HW; Choi JC
    PLoS One; 2017; 12(10):e0185774. PubMed ID: 28968457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for deterioration of nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kim SJ; Park J; Lee H; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):730-6. PubMed ID: 24903946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serodiagnostic potential of Mycobacterium avium MAV2054 and MAV5183 proteins.
    Shin AR; Lee KS; Lee KI; Shim TS; Koh WJ; Jeon HS; Son YJ; Shin SJ; Kim HJ
    Clin Vaccine Immunol; 2013 Feb; 20(2):295-301. PubMed ID: 23269416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease.
    Lee BY; Kim S; Hong Y; Lee SD; Kim WS; Kim DS; Shim TS; Jo KW
    Antimicrob Agents Chemother; 2015; 59(6):2972-7. PubMed ID: 25753634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
    Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
    Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.